Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_assertion type Assertion NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_head.
- NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_assertion description "[To clarify the molecular mechanisms through which malignant changes are activated in endometrium, this study aims to examine the expression profiles of wild-type ER-alpha and their splice variants and to assess the number of coexisting mRNA isoforms of ER-alpha in normal endometrium as well as in endometrial hyperplasia and endometrial endometrioid adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_provenance.
- NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_assertion evidence source_evidence_literature NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_provenance.
- NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_assertion SIO_000772 17561234 NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_provenance.
- NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_assertion wasDerivedFrom befree-20140225 NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_provenance.
- NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_assertion wasGeneratedBy ECO_0000203 NP745649.RAOLs2FpdrADQNp_TfNc1Hc2YiebLgiKh4SVx4QLB0hBY130_provenance.